title: Paraganglioma of the pituitary fossa: diagnosis and management.
abstract: Paraganglioma of the sellar area is extremely rare with only six cases having been reported in the literature. Surgical removal of these tumors is difficult, and the transsphenoidal approach usually results in limited resection. Most authors who published reports on this tumor recommended radiation therapy after partial removal of the tumor. However, considering the benign nature of these tumors, the risk of radiation-induced endocrine insufficiency and optic neuropathy and the lack of proven effectiveness of radiotherapy, its value remains controversial. We describe a 48-year-old woman with parasellar paraganglioma who presented with headaches, visual loss and oligomenorrhea. Magnetic resonance imaging (MRI) showed an invasive tumor in the sellar and parasellar areas which extended to both cavernous sinuses and compressed the optic chiasm and the left internal carotid artery. Surgery by the transsphenoidal approach enabled only limited biopsy of the tumor. The patient was reoperated by an extended pterional approach which resulted in a subtotal removal of the tumor and adequate decompression of the adjacent structures. She received no adjuvant treatment during the 8-year postsurgical follow-up and remained in good health. A repeated MRI showed no change in the size of the residual tumor. Contrary to the therapeutic recommendations described in previous reports, we favor postoperative adjuvant therapy only if the symptoms or signs of cranial nerve compression persist following maximal tumor removal, or if there is evidence of subsequent growth of residual tumor.
authors.affiliation: Department of Neurosurgery, Tel Aviv Sourasky Medical Center the Sackler Faculty of Medicine, Tel Aviv University, Israel. salame@tasmc.health.gov.il
authors.forename: K
authors.initials: K
authors.lastname: Salame
authors.forename: G E
authors.initials: GE
authors.lastname: Ouaknine
authors.forename: J
authors.initials: J
authors.lastname: Yossipov
authors.forename: S
authors.initials: S
authors.lastname: Rochkind
mesh_terms: D019797:3-Iodobenzylguanidine / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D010235:Paraganglioma / Q000175:diagnosis / Q000601:surgery / Q000628:therapy*; D010911:Pituitary Neoplasms / Q000175:diagnosis / Q000601:surgery / Q000628:therapy*; D019275:Radiopharmaceuticals / Q000627:therapeutic use; D016634:Radiosurgery; D019690:Technetium Tc 99m Exametazime; D015899:Tomography, Emission-Computed, Single-Photon; D014057:Tomography, X-Ray Computed
chemical_list: D019275:Radiopharmaceuticals; D019797:3-Iodobenzylguanidine; D019690:Technetium Tc 99m Exametazime